Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 14,556 | 15,690 | 15,060 | 14,945 | 14,314 |
| Cost of Goods | 953 | 1,122 | 1,180 | 896 | 774 |
| Gross Profit | 13,603 | 14,568 | 13,880 | 14,049 | 13,540 |
| Operating Expenses | 16,489 | 16,960 | 14,216 | 14,559 | 16,586 |
| Operating Income | -2,886 | -2,392 | -336 | -510 | -3,046 |
| Interest Expense | 1,802 | 1,788 | 1,859 | 1,703 | 1,606 |
| Other Income | 1,137 | 663 | 403 | 193 | 173 |
| Pre-tax Income | -3,551 | -3,517 | -1,792 | -2,020 | -4,479 |
| Income Tax | 65 | 671 | 187 | 177 | 274 |
| Net Income Continuous | -3,616 | -4,188 | -1,979 | -2,197 | -4,753 |
| Net Income | $-3,616 | $-4,188 | $-1,979 | $-2,197 | $-4,753 |
| EPS Basic Total Ops | -0.11 | -0.13 | -0.06 | -0.07 | -0.15 |
| EPS Basic Continuous Ops | -0.11 | -0.13 | -0.06 | -0.07 | -0.15 |
| EPS Diluted Total Ops | -0.11 | -0.13 | -0.06 | -0.07 | -0.15 |
| EPS Diluted Continuous Ops | -0.11 | -0.13 | -0.06 | -0.07 | -0.15 |
| EBITDA(a) | $6,638 | $6,316 | $7,439 | $7,163 | $4,494 |